Metformin for preventing the progression of chronic kidney disease

This review aims to assess the effect of metformin therapy on kidney function in patients with CKD. The safety and dose tolerability of metformin use in this population will also be assessed.

This is a protocol.

Health topics:

Kidney disease > Chronic kidney disease > Other treatments

Published:

5 September 2019

Authors:

El-Damanawi R, Viecelli AK, Pascoe EM, Craig JC, Johnson DW, Mallett AJ, Hawley CM, Hiemstra TF

Primary Review Group:

Kidney and Transplant Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
El-Damanawi R, Viecelli AK, Pascoe EM, Craig JC, Johnson DW, Mallett AJ, Hawley CM, Hiemstra TF. Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013414. DOI: 10.1002/14651858.CD013414

Don't show again

What role do you identify with the most?

General public, patient, or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.